An outbreak of Corona virus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-coV-2) occurred in Wuhan city, Hubei province, China in December 2019. Pulmonary health has been the main focus of studies of COVID-19, current articles show that cutaneous signs appear in COVID-19 patients, their identification may be vital to early diagnosis and lead to possible better prognosis in COVID-19 patients
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Frequency of skin manifestations in 1206
Timeframe: From day of randomisation until development of skin manifestations or not, assessed upto 12 months
COVID-19 Disease Outcome in patients with skin manifestations
Timeframe: Disease outcome during this 12 months duration of study.
Cutaneous patterns
Timeframe: From day of randomisation until development of skin manifestations or not, assessed upto 12 months
Association of COVID-19 disease outcome in correlation with skin manifestation
Timeframe: From day of randomisation until development of skin manifestations or not, until COVID-19 disease outcome (improved, worsen or death) assessed upto 12 months
Skin symptoms
Timeframe: From day of randomisation until development of skin manifestations or not, assessed upto 12 months
Duration of skin manifestations
Timeframe: From day of randomisation until development of skin manifestation or not, if development/already developed skin manifestations then resolution of it or for how long it persisted, assessed upto 12 months
The time of onset of skin manifestations
Timeframe: From day of randomisation until development of systemic manifestations or not, in patients with skin manifestations assessed upto 12 months
Presence or absence of systemic symptoms in COVID-19 patients
Timeframe: Day 1 of randomisation until development of systemic symptoms in patients with skin manifestations in upto 12 months